Asahi Intecc has announced that it will start the commercial distribution of its neurovascular guidewires (Asahi Chikai and Asahi Chikai 10) in the United States and Europe in January 2013.
The Asahi Chikai and Asahi Chikai 10 micro guidewires were developed as workhorse devices to treat intracranial aneurysms and cerebral arteriovenous fistulas and malformations. The guidewires have been sold in Japan since January 2010. According to the company, the guidewires balance distal flexibility with precise torqueability to ensure optimal performance in neurological interventional procedures.
Approximately 110,000 cerebrovascular procedures are performed annually in Japan, the United States and Europe, according to Asahi Intecc.
The guidewires will be sold via a direct sales team in the United States and through local distributors in Europe.